87 related articles for article (PubMed ID: 21736521)
1. Formulation, pharmacokinetics and biodistribution of Ofloxacin-loaded albumin microparticles and nanoparticles.
Lee KN; Ye Y; Carr JH; Karem K; D'Souza MJ
J Microencapsul; 2011; 28(5):363-9. PubMed ID: 21736521
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of levofloxacin-liposomes for the treatment of pulmonary inflammation.
Zhang X; Sun P; Bi R; Wang J; Zhang N; Huang G
J Drug Target; 2009 Jun; 17(5):399-407. PubMed ID: 19263265
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
[TBL] [Abstract][Full Text] [Related]
4. Ofloxacin targeting to lungs by way of microspheres.
Harsha S; R C; Rani S
Int J Pharm; 2009 Oct; 380(1-2):127-32. PubMed ID: 19646516
[TBL] [Abstract][Full Text] [Related]
5. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
[TBL] [Abstract][Full Text] [Related]
6. Gelatin nanocarriers as potential vectors for effective management of tuberculosis.
Saraogi GK; Gupta P; Gupta UD; Jain NK; Agrawal GP
Int J Pharm; 2010 Jan; 385(1-2):143-9. PubMed ID: 19819315
[TBL] [Abstract][Full Text] [Related]
7. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice.
Bibby DC; Talmadge JE; Dalal MK; Kurz SG; Chytil KM; Barry SE; Shand DG; Steiert M
Int J Pharm; 2005 Apr; 293(1-2):281-90. PubMed ID: 15778066
[TBL] [Abstract][Full Text] [Related]
9. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin.
Li L; Gao FP; Tang HB; Bai YG; Li RF; Li XM; Liu LR; Wang YS; Zhang QQ
Nanotechnology; 2010 Jul; 21(26):265601. PubMed ID: 20522924
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ofloxacin in broiler chicken.
Kalaiselvi L; Sriranjani D; Ramesh S; Sriram P; Mathuram LN
J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
[TBL] [Abstract][Full Text] [Related]
11. Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin-palladium complex.
Palazzo F; Giovagnoli S; Schoubben A; Blasi P; Rossi C; Ricci M
Int J Pharm; 2013 Jan; 440(2):273-82. PubMed ID: 22659124
[TBL] [Abstract][Full Text] [Related]
12. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.
Bansal A; Kapoor DN; Kapil R; Chhabra N; Dhawan S
Acta Pharm; 2011 Jun; 61(2):141-56. PubMed ID: 21684843
[TBL] [Abstract][Full Text] [Related]
13. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Ye J; Wang Q; Zhou X; Zhang N
Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
[TBL] [Abstract][Full Text] [Related]
14. Biodistribution of antisense nanoparticles in mammary carcinoma rat model.
Elazar V; Adwan H; Rohekar K; Zepp M; Lifshitz-Shovali R; Berger MR; Golomb G
Drug Deliv; 2010 Aug; 17(6):408-18. PubMed ID: 20429847
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
[TBL] [Abstract][Full Text] [Related]
16. Effect of levofloxacin and pefloxacin on humoral immune response elicited by bovine serum albumin docked in gelatin microparticles and nanoparticles.
Madan J; Kaushik D; Sardana S; Ali A; Sudhakaran Sudheesh M; Shankar Pandey R
Pharmazie; 2010 Apr; 65(4):284-9. PubMed ID: 20432626
[TBL] [Abstract][Full Text] [Related]
17. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K
J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095
[TBL] [Abstract][Full Text] [Related]
18. Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis.
Hwang SM; Kim DD; Chung SJ; Shim CK
J Control Release; 2008 Jul; 129(2):100-6. PubMed ID: 18538437
[TBL] [Abstract][Full Text] [Related]
19. Brain delivery and systemic effect of cationic albumin conjugated PLGA nanoparticles.
Xu F; Lu W; Wu H; Fan L; Gao X; Jiang X
J Drug Target; 2009 Jul; 17(6):423-34. PubMed ID: 19527113
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable microparticulate system of captopril.
Dandagi PM; Mastiholimath VS; Patil MB; Gupta MK
Int J Pharm; 2006 Jan; 307(1):83-8. PubMed ID: 16310990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
